In the following video, Motley Fool health-care analyst David Williamson takes a question from a Fool reader, who asks, "Should I buy, sell or hold Teva Pharmaceutical Industries Limited (TEVA -0.71%)?"
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Ask a Fool: Buy, Sell or Hold Teva?
By Dave Williamson
–
Jun 27, 2013 at 5:43PM
NYSE: TEVA
Teva Pharmaceutical Industries
Market Cap
$16B
Today's Change
(-0.71%) -$0.10
Current Price
$13.98
Price as of May 3, 2024, 4:00 p.m. ET
Is Teva too dangerous to buy right now?
David Williamson has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Related Articles
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
Teva Pharmaceutical Industries (TEVA) Q3 2023 Earnings Call Transcript
Teva Pharmaceutical Industries (TEVA) Q2 2023 Earnings Call Transcript
3 Bargain Stocks to Buy on the Dip
Teva Pharmaceuticals Just Made a Big Announcement, but Is It a Buy?
650%
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.